Get started
Author

Yu-Hsiu Chang

Observed name: Yu-hsiu Chang
ORCID: 0000-0002-3471-1033
Observed ORCID: 0000-0002-3471-1033
OpenAlex ID: A5101313790
PCR Assay of the groEL Gene for Detection and Differentiation of Bacillus cereus Group Cells
2003 · Yu-Hsiu Chang, Yung-Hui Shangkuan, et al. · Applied and Environmental Microbiology · 72
Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation
2021 · Wen-Fang Tang, Hui-Ping Tsai, et al. · Biomedical Journal · 61
dsRNA Binding Domain of PKR Is Proteolytically Released by Enterovirus A71 to Facilitate Viral Replication
2017 · Yu-Hsiu Chang, Kean Seng Lau, et al. · Frontiers in Cellular and Infection Microbiology · 32
PDF
Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3β and phosphorylated AKT expression levels
2022 · Jia-Rong Jheng, Chung-Fan Hsieh, et al. · Journal of Microbiology Immunology and Infection · 24
PDF
Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model
2022 · Yun-Ti Chen, Yu-Hsiu Chang, et al. · Frontiers in Immunology · 15
PDF
Mosquito Cell-Derived Japanese Encephalitis Virus-Like Particles Induce Specific Humoral and Cellular Immune Responses in Mice
2020 · Yu-Hsiu Chang, Der-Jiang Chiao, et al. · Viruses · 15
PDF
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir
2024 · Wen-Fang Tang, Yu-Hsiu Chang, et al. · Antimicrobial Agents and Chemotherapy · 12
PDF
Humoral, Cellular and Cytokine Immune Responses Against SARS-CoV-2 Variants in COVID-19 Convalescent and Confirmed Patients With Different Disease Severities
2022 · Chun-Hsiang Chiu, Yu-Hsiu Chang, et al. · Frontiers in Cellular and Infection Microbiology · 11
Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants
2022 · Chun-Hsiang Chiu, Yu-Hsiu Chang, et al. · Microbiology Spectrum · 8
Cloning and Characterization of the Replicon of the Nocardia italica Plasmid, pNI100
2000 · Yu-Tien Liu, Chih-Mao Su, et al. · Plasmid · 6
Microfluidic Synthesis of Quaternary Chitosan Coated Liposome to Enhance Cellular Uptake and In Vivo Immune Responses
2024 · Chuan-Chang Chuang, Chuan-Chang Chuang, et al. · ACS Applied Nano Materials · 3
Targeting SARS-CoV-2 RNA-dependent RNA polymerase with the coumarin derivative BPR2-D2: Evidence from cell-based and enzymatic studies
2025 · Wen-Fang Tang, Hui-Ping Tsai, et al. · Biomedicine & Pharmacotherapy · 2
Protein disulphide isomerase A4 as a potential biomarker for coronavirus disease 2019: Correlation with cytokine profiles and disease progression
2025 · Yu-Hsiu Chang, Ying‑Chuan Wang, et al. · Virulence · 2
Enhancing the in vivo efficacy of anthrax vaccine using trimethylchitosan covalently coated chitosomes in a single-step microfluidic synthesis
2025 · Chuan-chung Chuang, Chuan-chung Chuang, et al. · International Journal of Biological Macromolecules · 2
A Selective Histone Deacetylase 6 Inhibitor Showed Antiviral Activity Against Dengue and Zika Viruses
2023 · Hao-Wen Shih, Chang-Huei Tsao, et al. · Journal of Medical Sciences · 2
Natural killer T cells play a significant role in preventing Coxsackievirus A10 infection through an adeno-based vaccine expressing enterovirus-like particles
2025 · Shu-Ling Yu, Nai-Hsiang Chung, et al. · Vaccine · 1
Interplay of COVID-19 and Physiological Dysfunctions
2020 · Yu-Hsiu Chang, Chih-Heng Huang, et al. · The Chinese Journal of Physiology
Works count: 17
Citation count: 268
H-index: 8
I10-index: 8
Year
Topic
Type